Youth Vaping Is "Predictable" by Design - Scorecard - MDSpire

Youth Vaping Is "Predictable" by Design

  • By

  • Kerri Miller

  • June 5, 2026

  • 3 min

Share

Clinical Scorecard: Youth Vaping Is 'Predictable' by Design

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationAdolescents aged 13 to 15 years
Care Setting

Key Highlights

  • Vaping prevalence among adolescents is nine times that of adults.
  • E-cigarette products with at least 5% nicotine strength increased by 1,486% from 2017 to 2022.
  • Evidence of harms in youth includes addiction, toxicity, and increased smoking uptake.
  • Long-term effects of e-cigarettes on clinical outcomes remain uncertain.

Guideline-Based Recommendations

Diagnosis

  • Recognize nicotine dependence in adolescents as influenced by product design and marketing.

Management

  • Implement pre-market safety standards and retailer licensing reform.

Monitoring & Follow-up

  • Monitor youth exposure to e-cigarettes and related health outcomes.

Risks

  • Acknowledge risks of addiction, toxicity, and other health harms associated with vaping.

Patient & Prescribing Data

Adolescents at risk of nicotine dependence due to vaping.

Focus on addressing upstream factors such as product design and marketing.

Clinical Best Practices

  • Incorporate discussions of product design and commercial systems in counseling.
  • Advocate for flavor restrictions and comprehensive tobacco control measures.

Related Resources & Content

Original Source(s)

Related Content